Atlas Trials

Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia

Clinical trial NCT00263081 · TERMINATED

Trial details

NCT number
NCT00263081
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2005-11-01
Primary completion
2007-03-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.